Please Wait
Applying Filters...

End Use API

Request an Update of Your Company Information, Events & Sales Content

CAS Number

138113-08-3

End Use API

AGOMELATINE

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

865758-96-9

End Use API

ALOGLIPTIN BENZOATE

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

334618-23-4

End Use API

ALOGLIPTIN BENZOATE

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

155742-64-6

End Use API

Aprepitant

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

171482-05-6

End Use API

Aprepitant

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

6296-53-3

End Use API

Apremilast

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

76801-85-9

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

198479-63-9

End Use API

Bazedoxifene Acetate

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

223251-25-0

End Use API

Bazedoxifene Acetate

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

198480-21-6

End Use API

Bazedoxifene Acetate

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1132832-76-8

End Use API

Canagliflozin

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

78573-45-2

End Use API

Cinacalcet

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

212322-56-0

End Use API

dabigatran

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

81058-27-7

End Use API

Dapagliflozin

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

2147-83-3

End Use API

Droperidol

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1210348-34-7

End Use API

Edoxaban

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

61747-22-6

End Use API

Fluvoxamine

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

85175-59-3

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

880468-89-3

End Use API

Lacosamide

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1253790-58-7

End Use API

Lacosamide

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

853029-57-9

End Use API

Linagliptin

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

334618-23-4

End Use API

Linagliptin

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

13127-18-19

End Use API

Tylosin

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

521284-22-0

End Use API

Mirabegron

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

End Use API

Dinoprostone

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

446292-08-6

End Use API

Rivaroxaban

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

898543-06-1

End Use API

Rivaroxaban

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

380380-64-3

End Use API

Torezolid Phosphate

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

145980-33-2

End Use API

Tenofovir

Supporting Information

View All Icon

About the Company

Mehta API is EU-GMP by Swiss-Medic (PICS), ED...

Mehta API is EU-GMP by Swiss-Medic (PICS), EDQM, TGA, WHO -GMP certified & PMDA US-FDA approvable facility with land area 26,580 sq. mt. It is a research driven organization, focusing on development, using green chemistry, manufacturing and marketing of API’s- multi step, highly complex, potent, chiral & semi-synthetic, Advance intermediates, specialty chemicals and building blocks. We are committed to Excellence in Product Quality and adherence to agreed delivery schedule. We export to about 20 countries including Regulated Markets spanning all 6 continents, developing technology and translating to production and delivery to customers.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

13951-70-7

End Use API

Budesonide

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

981-34-0

End Use API

Betamethasone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

82543-15-5

End Use API

Drospirenone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

82543-16-6

End Use API

Drospirenone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

98319-24-5

End Use API

Finasteride

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

68-96-2

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

302-23-8

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

15339-87-8

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

6870-94-6

End Use API

Methylprednisolone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

3962-66-1

End Use API

Mifepristone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

24916-90-3

End Use API

Mifepristone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

84371-57-3

End Use API

Mifepristone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

84371-64-2

End Use API

Mifepristone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

24916-90-3

End Use API

Mometasone Furoate

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

24916-90-3

End Use API

Flumethasone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

734-32-7

End Use API

Norethindrone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

119302-20-4

End Use API

ROCURONIUM BROMIDE

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

37413-20-4

End Use API

Triamcinolone

Supporting Information

View All Icon

About the Company

With the high technology and excellent servic...

With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific research since we were established in 1972.We developed over 100 Active Pharmaceutical Ingredients and finished formulations from then on , becoming a leader of steroids and hormones manufacturing in China. Xianju pharma has full of confidence to be a global supplier of active pharmaceutical ingredients with customized solid state specifications and unparalleled intellectual property that accomplishment our cooperation.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

161798-03-4

End Use API

Febuxostat

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

161798-01-2

End Use API

Febuxostat

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1516887-33-4

End Use API

Obeticholic Acid

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

863239-59-2

End Use API

Obeticholic Acid

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

10538-59-7

End Use API

Obeticholic Acid

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

865758-96-9

End Use API

ALOGLIPTIN BENZOATE

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

334618-23-4

End Use API

ALOGLIPTIN BENZOATE

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

End Use API

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

End Use API

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

159857-80-4

End Use API

Supporting Information

View All Icon

About the Company

Waterstone is an international pharmaceutical...

Waterstone is an international pharmaceutical company with its main operations in China. The company is focused in discovery, development and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. With venture capital investments from internationally well-known firms such as BAR Capital, CID Group, Orbimed, and Acorn Camps, the company has established fully integrated capabilities from R&D, API & Finished Drug Product manufacturing to sales/marketing. The company has a strong management team with cross-border experience and advisors with expertise in drug discovery, regulatory, and GMP manufacturing. On top of the forty marked drugs in China, the company has also built a rich pipeline including Drug Master Files with U.S. FDA , candidates in phase II/III clinical tries with cFDA, and several novel preclinical stage antiviral and oncology candidates

Request an Update of Your Company Information, Events & Sales Content

CAS Number

109010-60-8

End Use API

Benazepril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

82717-96-2

End Use API

Bonuten

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

84793-24-8

End Use API

Bonuten

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

137590-32-0

End Use API

Fosinopril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

90657-55-9

End Use API

Fosinopril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

103201-78-1

End Use API

Fosinopril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

77497-97-3

End Use API

Quinapril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

74163-81-8

End Use API

Quinapril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

93779-29-4

End Use API

Ramipril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

103300-91-0

End Use API

Lisinopril

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124751-00-4

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

114772-55-3

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

114798-26-4

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

109887-53-8

End Use API

Paroxetine

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

105812-81-5

End Use API

Paroxetine

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

110429-36-2

End Use API

Paroxetine

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124750-51-2

End Use API

LOSARTAN POTASSIUM

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

138401-24-8

End Use API

Irbesartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

6306-52-1

End Use API

Valsartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

482577-59-3

End Use API

Valsartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

144689-93-0

End Use API

Olmesartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

144690-33-5

End Use API

Olmesartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

144690-92-6

End Use API

Olmesartan

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

139481-41-7

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

139481-59-7

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

139481-44-0

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

139481-72-4

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

170791-09-0

End Use API

Candesartan Cilexetil

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

133627-45-9

End Use API

Nevirapine

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

133627-46-0

End Use API

Nevirapine

Supporting Information

View All Icon

About the Company

Zhejiang Huahai Pharmaceuticals Co., Ltd.was ...

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai. It occupies an area of 800,000 square meters, and has a staff of 3400. The company is entitled as National Key Hi-tech Enterprise,National Pilot Enterprise of Innovation, and China's top 500 private enterprises, and possesses a "State Certified Enterprise Technology Center". Huahai Pharmaceuticals is the largest supplier of pril products worldwide, with the annual production capacities of its dominating products "captopril" and "enalapril" both ranking first in the world. It is also the only manufacturer in the world that can realize commercial production of captopril, enalapril and lisinopril at the same time, enjoying the reputation of a "Pril Specialist". The pril drugs of the company boast absolute advantages in international markets in terms of production scale, product quality, technological skills and R&D. The company's workshops of formulation are designed in strict compliance with the international cGMP standard, where the most advanced automatic pharmaceutical production equipment in the world was introduced. We are the first pharmaceutical company in China that has passed USA FDA approval.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

181289-15-6

End Use API

Pregabalin

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

181289-33-8

End Use API

Pregabalin

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

131801-69-9

End Use API

Venlafaxine

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

93413-77-5

End Use API

Venlafaxine

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

93413-69-5

End Use API

Venlafaxine

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

111974-74-4

End Use API

Quetiapine

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

124832-31-1

End Use API

Valacyclovir

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

149105-26-0

End Use API

Gemfibrozil

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

34911-51-8

End Use API

Bupropion

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

64744-50-9

End Use API

Gabapentin

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

189400-21-3

End Use API

Olmesartan

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

144690-92-6

End Use API

Olmesartan

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

244634-31-9

End Use API

Darunavir

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

206361-99-1

End Use API

Darunavir

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1253790-58-7

End Use API

Lacosamide

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

211915-06-9

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

486460-32-6

End Use API

Sitagliptin

Supporting Information

View All Icon

About the Company

Hikal is an established provider of research ...

Hikal is an established provider of research services, active ingredients, intermediates and regulatory starting materials under cGMP conditions to the Pharmaceutical, Crop Protection and Specialty Chemicals industry. Our manufacturing facilities located in India have also been certified by the US FDA, TGA, PMDA and are ISO 9001:2008, ISO 14001, OHSAS 18001 certified and audited by global innovator, generic and biotech companies. We are a 'Responsible Care' certified company which values and respects the Intellectual property rights of our customers.Strengths: Custom Synthesis; Contract Manufacturing; Process Development, Scale-up expertise; Product Development and Life cycle extension. Intermediates, Advanced Intermediates and API's

Request an Update of Your Company Information, Events & Sales Content

CAS Number

118864-75-8

End Use API

Solifenacin

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

25333-42-0

End Use API

Solifenacin

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

5834-16-2

End Use API

Morantel Tartrate

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1193-65-3

End Use API

Palonosetron

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1193-65-3

End Use API

Solifenacin

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

1193-65-3

End Use API

Clidinium

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

6238-13-7

End Use API

Clidinium

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

64168-68-9

End Use API

Cevimeline

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

625120-81-2

End Use API

IBANDRONATE SODIUM

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

693-05-0

End Use API

Alfuzosin HCl

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

22884-10-2

End Use API

Zoledronic Acid

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

105462-24-6

End Use API

Risedronic Acid

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

13636-02-7

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

90-41-5

End Use API

Saccharin Sodium

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

90-41-5

End Use API

isometamidium

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

166975-76-4

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

10226-30-9

End Use API

Pentoxifylline

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

22246-18-0

End Use API

Aripiprazole

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.

Request an Update of Your Company Information, Events & Sales Content

CAS Number

78573-45-2

End Use API

Cinacalcet

Supporting Information

View All Icon

About the Company

RR LIFESCIENCES manufactures products purely ...

RR LIFESCIENCES manufactures products purely by organic synthesis to offer its customers a choice of products in their areas. Our facilities are equipped with a range of reactor sizes, glass lined reactors and S.S. Reactors, some reactors are capable of operating at high extreme temperature. Other equipments includes Centrifuges, Vacuum Tray Drier, Multi Mills, Tray Drier, in clean finishing suites. All Our facilities are GMP complaint, designed to maintain the highest standards of safety. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products. Our R&D scale-up capabilities from lab scale to commercialization. Our team of experts interacts with our customers from the initial stages of the project to ensure successful completion of the project. We follow stringent quality assurance norms and it has the domain expertise and state of art of facilities to develop analytical methods for evaluating quality of raw materials, intermediates and final products.